[PERSONALIZED MEDICINE IN INTERNAL MEDICINE].

V. Kukes, V. Marinin, Yu. V. Olefir, G. Ramenskaya, N. Lazareva, V. Smirnov, M. Zhuravleva, A. Prokofiev, E. Shih, A. Zhestovskaia, N. Rumyantsev, D. Mandich, O. Goroshko
{"title":"[PERSONALIZED MEDICINE IN INTERNAL MEDICINE].","authors":"V. Kukes, V. Marinin, Yu. V. Olefir, G. Ramenskaya, N. Lazareva, V. Smirnov, M. Zhuravleva, A. Prokofiev, E. Shih, A. Zhestovskaia, N. Rumyantsev, D. Mandich, O. Goroshko","doi":"10.18821/0023-2149-2017-95-3-197-200","DOIUrl":null,"url":null,"abstract":"Personalized medicine - a new direction in medicine, which is based on the study of various biomarkers and the use of new methods of molecular analysis (primarily evaluating the activity of isoenzymes of cytochrome P450), allowing individualized approach to the selection of both the drugs and the selection of the dosing regimen for the purpose of maximize the effectiveness and safety of pharmacotherapy. This personalized medicine is to change the development and use of preventive and curative interventions. Genetic polymorphism isozymes of cytochrome P450 may determine the individual activity of a particular isozyme, and thus, to predict the clinical effectiveness, and in some cases, the risk of adverse reactions. The article is an example of the use of information on the activity of cytochrome P450 in clinical practice in matters of diagnosis, treatment and prevention of diseases. The scheme of the five best-known activity of isoenzymes of cytochrome P450 is shown.","PeriodicalId":17856,"journal":{"name":"Klinicheskaia meditsina","volume":"53 1","pages":"197-200"},"PeriodicalIF":0.0000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Klinicheskaia meditsina","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18821/0023-2149-2017-95-3-197-200","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Personalized medicine - a new direction in medicine, which is based on the study of various biomarkers and the use of new methods of molecular analysis (primarily evaluating the activity of isoenzymes of cytochrome P450), allowing individualized approach to the selection of both the drugs and the selection of the dosing regimen for the purpose of maximize the effectiveness and safety of pharmacotherapy. This personalized medicine is to change the development and use of preventive and curative interventions. Genetic polymorphism isozymes of cytochrome P450 may determine the individual activity of a particular isozyme, and thus, to predict the clinical effectiveness, and in some cases, the risk of adverse reactions. The article is an example of the use of information on the activity of cytochrome P450 in clinical practice in matters of diagnosis, treatment and prevention of diseases. The scheme of the five best-known activity of isoenzymes of cytochrome P450 is shown.
[内科个体化医疗]。
个体化医学——医学的一个新方向,它基于对各种生物标志物的研究和使用新的分子分析方法(主要是评估细胞色素P450同工酶的活性),允许个体化方法来选择药物和选择给药方案,以最大限度地提高药物治疗的有效性和安全性。这种个性化医疗将改变预防和治疗干预措施的发展和使用。细胞色素P450基因多态性同工酶可以决定特定同工酶的个体活性,从而预测临床疗效,在某些情况下,还可以预测不良反应的风险。这篇文章是在诊断、治疗和预防疾病的临床实践中使用细胞色素P450活性信息的一个例子。给出了细胞色素P450同工酶的5种最著名的活性谱图。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信